Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Collins, Samuel L ^a   Hervé, Rodolphe ^a   Keevil, C W ^a   Blaydes, Jeremy P ^b   Webb, Jeremy S ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; ADENOSINE TRIPHOSPHATASE; DNA BINDING PROTEIN; MLH1 PROTEIN, HUMAN; MLH1 PROTEIN, MOUSE; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; PMS2 PROTEIN, MOUSE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN TUMOR; CARCINOGENESIS; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MISMATCH REPAIR; MLH1 GENE; MOUSE; MULTICELLULAR SPHEROID; NEUROBLASTOMA; NONHUMAN; PMS2 GENE; TUMOR GROWTH; TUMOR SPHEROID; ANIMAL; DRUG ANTAGONISM; GENETICS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ANIMALS; BRAIN NEOPLASMS; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEUROBLASTOMA; NUCLEAR PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 82455174374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028123     Document Type: Article

References (56)

1. Sutherland R, Carlsson J, Durand R, Yuhas J, (1981) Spheroids in cancer-research. Cancer Res 41: 2980-2984.
2. Sutherland R, MacDonald HR, Howell RL, (1977) Multicellular spheroids: a new model target for in vitro studies of immunity to solid tumor allografts. J Natl Cancer Inst 58: 1849-1853.
3. Sutherland R, McCredie JA, Inch WR, (1971) Growth of multicellular spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst 46: 113.
4. Kunz-Schughart LA, (1999) Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol Int 23: 157-161.
5. Francia G, Man S, Teicher B, Grasso L, Kerbel RS, (2004) Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents. Mol Cell Biol 24: 6837-6849.
6. Takagi A, Watanabe M, Ishii Y, Morita J, Hirokawa Y, et al. (2007) Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features. Anticancer Res 27: 45-53.
7. Ronen S, Degani H, (1989) Studies of the Metabolism of Human-Breast Cancer Spheroids by Nmr. Magn Res Med 12: 274-281.
8. Kumar HR, Zhong XL, Hoelz DJ, Rescorla FJ, Hickey RJ, et al. (2008) Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids. Pediatric Surgery International 24: 1229-1234.
9. Condat CA, Menchon SA, (2006) Ontogenetic growth of multicellular tumor spheroids. Physica a-Statistical Mechanics and Its Applications 371: 76-79.
10. Drasdo D, Hohme S, (2005) A single-cell-based model of tumor growth in vitro: monolayers and spheroids. Physical Biol 2: 133-147.
11. Helmlinger G, Netti PA, Lichtenbeld HC, Melder RJ, Jain RK, (1997) Solid stress inhibits the growth of multicellular tumor spheroids. Nat Biotechnol 15: 778-783.
12. Luk CK, Keng PC, Sutherland R, (1986) Radiation response of proliferating and quiescent subpopulations isolated from multicellular spheroids. Br J Cancer 54: 25-32.
13. Genc M, Castro Kreder N, Barten-van Rijbroek A, Stalpers LJ, Haveman J, (2004) Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids. J Cancer Res Clin Oncol 130: 45-51.
14. Kerr DJ, Kaye SB, (1987) Aspects of cytotoxic drug penetration, with particular reference to anthracyclines. Cancer Chemother Pharmacol 19: 1-5.
15. Wu LY, Di Carlo D, Lee LP, (2008) Microfluidic self-assembly of tumor spheroids for anticancer drug discovery. Biomedical Microdevices 10: 197-202.
16. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C, (1999) Genetic instability and darwinian selection in tumours. Trends in Biochemical Sciences 24: M57-M60.
17. Kerbel RS, (1990) Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res 55: 87-132.
18. Loeb LA, Bielas JH, Beckman RA, (2008) Cancers exhibit a mutator phenotype: Clinical implications. Cancer Res 68: 3551-3557.
19. Francia G, Green SK, Bocci G, Man S, Ernmenegger U, et al. (2005) Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents. Mol Cancer Ther 4: 1484-1494.
20. Kolodner RD, Marsischky GT, (1999) Eukaryotic DNA mismatch repair. Curr Opin Genetics Dev 9: 89-96.
21. Jiricny J, (2000) Mediating mismatch repair. Nat Genet 24: 6-8.
22. Kunkel TA, Erie DA, (2005) DNA mismatch repair. Annu Rev Biochem 74: 681-710.
23. Jiricny J, Nystrom-Lahti M, (2000) Mismatch repair defects in cancer. Curr Opin Genetics Dev 10: 157-161.
24. Peltomaki P, (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10: 735-740.
25. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, et al. (1994) Mutation in the DNA Mismatch Repair Gene Homolog Hmlh1 Is Associated with Hereditary Nonpolyposis Colon-Cancer. Nature 368: 258-261.
26. Hsieh P, Yamane K, (2008) DNA mismatch repair: Molecular mechanism, cancer, and ageing. Mech Ageing Dev 129: 391-407.
27. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, et al. (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2: 169-174.
28. Mueller J, Gazzoli I, Bandipalliam P, Garber JE, Syngal S, et al. (2009) Comprehensive molecular analysis of mismatch repair gene defects in suspected lynch syndrome (Hereditary Nonpolyposis Colorectal Cancer) cases. Cancer Res 69: 7053-7061.
29. Bindra RS, Crosby ME, Glazer PM, (2007) Regulation of DNA repair in hypoxic cancer cells. Cancer Metastasis Rev 26: 249-260.
30. Nicolaides NC, Littman SJ, Modrich P, Kinzler KW, Vogelstein B, (1998) A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype. Molecular and Cellular Biology 18: 1635-1641.
31. Loeb LA, (2001) A mutator phenotype in cancer. Cancer Res 61: 3230-3239.
32. Surtees JA, Argueso JL, Alani E, (2004) Mismatch repair proteins: key regulators of genetic recombination. Cytogenet Genome Res 107: 146-159.
33. Baker SM, Plug AW, Prolla TA, Bronner CE, Harris AC, et al. (1996) Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nature Genet 13: 336-342.
34. Davis TW, Wilson-Van Patten C, Meyers M, Kunugi KA, Cuthill S, et al. (1998) Defective expression of the DNA mismatch repair protein, MLH1, alters G(2)-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res 58: 767-778.
35. Pors K, Patterson LH, (2005) DNA mismatch repair deficiency, resistance to cancer chemotherapy and the development of hypersensitive agents. Current Topics in Medicinal Chemistry 5: 1133-1149.
36. Fink D, Aebi S, Howell SB, (1998) The role of DNA mismatch repair in drug resistance. Clinical Cancer Research 4: 1-6.
37. Mahller YY, Williams JP, Baird WH, Mitton B, Grossheim J, et al. (2009) Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. PLoS ONE 4: e4235.
38. Lagasse E, (2008) Cancer stem cells with genetic instability: the best vehicle with the best engine for cancer. Gene Therapy 15: 136-142.
39. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
40. Sell S, (2004) Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 51: 1-28.
41. Shackleton M, Quintana E, Fearon ER, Morrison SJ, (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138: 822-829.
42. Spillane JB, Henderson MA, (2007) Cancer stem cells: A review. Anz Journal of Surgery 77: 464-468.
43. Wu XZ, (2008) Origin of cancer stem cells: the role of self-renewal and differentiation. Ann Surg Oncol 15: 407-414.
44. Zhang M, Rosen JM, (2006) Stem cells in the etiology and treatment of cancer. Cur Opi Gen Dev 16: 60-64.
45. Reynolds TY, Rockwell S, Glazer PM, (1996) Genetic instability induced by the tumor microenvironment. Cancer Res 56: 5754-5757.
46. Papp-Szabo E, Josephy PD, Coomber BL, (2005) Microenvironmental influences on mutagenesis in mammary epithelial cells. Int J Cancer 116: 679-685.
47. Hammond EM, Green SL, Giaccia AJ, (2003) Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutat Res 532: 205-213.
48. Lindahl T, (1993) Instability and decay of the primary structure of DNA. Nature 362: 709-715.
49. Coquelle A, Toledo F, Stern S, Bieth A, Debatisse M, (1998) A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell 2: 259-265.
50. Young SD, Marshall RS, Hill RP, (1988) Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A 85: 9533-9537.
51. Mihaylova VT, Bindra RS, Yuan JL, Campisi D, Narayanan L, et al. (2003) Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol 23: 3265-3273.
52. Koshiji M, To KKW, Hammer S, Kumamoto K, Harris AL, et al. (2005) HIF-1 alpha induces genetic instability by transcriptionally downregulating MutS alpha expression. Mol Cel 17: 793-803.
53. Matheson EC, Hall AG, (2003) Assessment of mismatch repair function in leukaemic cell lines and blasts from children with acute lymphoblastic leukaemia (vol 24, pg 31, 2003). J Carcinog 24: 1285-1286.
54. Evans SM, Labs LM, Yuhas JM, (1986) Response of Human Neuroblastoma and Melanoma Multicellular Tumor Spheroids (Mts) to Single Dose Irradiation. IJROBP 12: 969-973.
55. Darling JL, Oktar N, Thomas DGT, (1983) Multicellular Tumor Spheroids Derived from Human-Brain Tumors. Cell Biology International Reports 7: 23-30.
56. Dunham LJ, Stewart HL, (1953) A survey of transplantable and transmissible animal tumors. J Natl Cancer Inst 13: 1299-1377.